Trial no.:
|
PACTR202204809082266 |
Date of Approval:
|
07/04/2022 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Early Outcomes of Banded versus Non-banded One Anastomosis Gastric Bypass: A Randomized Controlled Trial |
Official scientific title |
Early Outcomes of Banded versus Non-banded One Anastomosis Gastric Bypass: A Randomized Controlled Trial |
Brief summary describing the background
and objectives of the trial
|
It is now widely acknowledged that one anastomosis gastric bypass (OAGB) is at least as effective as Roux-en-Y gastric bypass (RYGB), if not more effective when it comes to weight loss and comorbidity resolution.
Although it has its own advantages, weight regain remains a significant concern after OAGB, weight loss may diminish by gastric pouch dilation. One other phenomenon is dumping syndrome in OAGB patients that reduces the patient`s quality of life. The placement of a band around the gastric pouch to increase the restriction of food intake is acknowledged as a possible way to maximize weight loss after RYGB. On the other hand, the incidence of food intolerance appears to be higher among individuals who underwent banded bypass. Recent works suggest that weight regain along with dumping syndrome might be limited by the placement of a silicone ring around the gastric pouch during the procedure. The placement of a band around the upper segment of the OAGB is thought to limit the volume of food intake and slow down the passage of food and prevent dilatation of the pouch distal to the ring in the long term. The band may hopefully help in maintaining the patient’s weight and can potentially prevent dumping syndrome. The purpose of this randomized controlled trial is to compare the early outcomes after banded versus non-banded OAGB as regard to weight loss and comorbidities resolution.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Morbid Obesity,Nutritional, Metabolic, Endocrine |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Surgery |
Anticipated trial start date |
15/04/2022 |
Actual trial start date |
|
Anticipated date of last follow up |
01/01/2024 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
42 |
Actual target sample size (number of participants) |
|
Recruitment status |
Not yet recruiting |
Publication URL |
N/A |
|